Articles Tagged With: Estrogen
-
Consider Vaginal Estrogen for Genitourinary Syndrome of Menopause
-
Consider Options for Women With Genitourinary Syndrome of Menopause
Sexual function often decreases for women because of the genitourinary syndrome of menopause (GSM). This condition includes the physical changes of the vulva, vagina, and lower urinary tract that result from estrogen deficiency.
-
Help Women Consider Options for Postmenopausal Vaginal Dryness
Data from a large longitudinal study indicate that more than 33% of women ages 57-69 report symptoms of vaginal dryness. However, research shows that more than 50% of women don’t report such conditions to their healthcare providers. Even fewer women take advantage of proven therapies such as vaginal estrogen tablets, creams, and rings.
-
Is Vaginal Estrogen Still the Gold Standard for Treating GSM?
In this 12-week randomized, controlled trial of 302 women, neither vaginal estrogen nor vaginal moisturizer was more effective than placebo for reducing the participants’ most bothersome symptom (pain with vaginal penetration, vulvovaginal itching, vulvovaginal pain, vaginal dryness, or vulvovaginal irritation).
-
Brain Imaging and Alzheimer’s Risk: Valid Surrogates or Just Pretty Pictures?
In an observational multimodality brain imaging study, investigators found sex and age differences correlated with endophenotypes of late-onset Alzheimer’s disease.
-
Hormone Replacement: Have We Made Progress Since WHI?
Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.
-
Vaginal Estrogen Found to Be Safe, Effective Option During Menopause
Results of recent research indicate that vaginal estrogen is effective and safe for the treatment of genitourinary symptoms. Such low-dose vaginal estrogen options keep blood levels within the normal postmenopausal range.
-
What Are Your Patients ‘Hearing’ About Menopausal Hormonal Therapy?
Data from the prospective Nurses’ Health Study demonstrate a weak association between menopause onset after age 50 years and use of hormone therapy and hearing loss. The most likely explanation is “noise.”
-
Hot Flashes: A Marker of Increased Cardiovascular Risk?
Among otherwise healthy midlife women, the presence of frequent hot flashes was associated with impaired endothelial function, a risk factor for cardiovascular disease.
-
Did You Remember to Take Your Hormone Replacement? The Treatment May Not Help
Women randomized to receive postmenopausal oral estradiol therapy did not show improved memory, executive function, or global cognition, and timing of initiation of hormonal treatment did not affect the outcome.